Biochips enable the accurate, rapid, and high-throughput detection of DNA, RNA, polypeptides, proteins, cells, tissues, and other biological components, with great advantages in disease screening and early diagnosis.

Stay up-to-date with the latest happenings in the rapidly evolving field of In Vitro Diagnostics (IVD) in China.

Stilla Technologies announced recently that it has completed a 16 million ($18.3 million) Series A financing round led by Illumina Ventures. Kurma Partners, LBO France, BNP Paribas Dveloppement, Paris Saclay Seeds, and Idinvest Partners als

Q: What did you do with the other embryos? Were they implanted? A: There are seven couples but the clinical trial is on hold due to the current situation. Q: What did you to get feedback on the clinical trial design? What was the scope of th

Antimicrobial resistance (AMR) threats to patient health are becoming more widely recognized and diagnostics manufacturers are making significant progress in combatting the overuse of antibiotics. There is still a lot of work to be done, how

Nearly 1,000 devices are included in a recall of GE Healthcares Millennium Nuclear Medical Systems after the top detector of one system detached and fell onto the detector below. FDA saidno patient injuries have been reported although there

The kilogram, kg, ampere, A, kelvin, K, and mole, mol, will have new definitions, but they will be so chosen that at the moment of change the magnitudes of the new units will be indistinguishable from those of the old units. The new definit

Just when it looked like the year would end without another mega-merger, Illumina has swooped in to acquire its rival, Pacific Biosciences (PacBio), for $1.2 billion. The move would solidify San Diego, CA-based Illuminas position in the gene

Each year in the United States, at least two million people become infected with antibiotic-resistant infections--so-called super bugs. And at least 23,000 of those people will end up dying from them, according to theCenters for Disease Cont

Anyone who has had BRCA1 or BRCA2 testing can log onto My Gene Counsel to learn about their gene and variant, and what they can do about the finding. Registered users of its recently launched patient portal can have their genetic test result

Ellen Matloff, president CEO of digital health company My Gene Counsel , says she was adamantly opposed to DTC testing just six years ago. But since then, 15 million people have had one done, and the number of DTC genetic companies has mushr

Bionano Genomics reported a 3 percent increase in third-quarter revenues after the market close recently. Fresh off its initial public offering in August, in which it raised $23.7 million in gross proceeds, the San Diego-based DNA analysis